Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Shapiro

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
Animals : an Open Access Journal From MDPI|May 16, 2017
A Decade of Progress toward Ending the Intensive Confinement of Farm Animals in the United StatesSara Shields, Paul Shapiro, Andrew Rowan
The Journal of Biological Chemistry|January 18, 2005
Protein phosphatase 2A activity associated with Golgi membranes during the G2/M phase may regulate phosphorylation of ERK2Chad N Hancock, Surabhi Dangi, Paul Shapiro
Advances in Pharmacology (San Diego, Calif.)|July 31, 2023
Progress in the development of kinase inhibitors for treating asthma and COPDNathaniel McClean, Jeffery D Hasday, Paul Shapiro
The Journal of Biological Chemistry|November 25, 2010
Quantitative analysis of ERK2 interactions with substrate proteins: roles for kinase docking domains and activity in determining binding affinityKimberly A Burkhard, Fengming Chen, Paul Shapiro
The Journal of Biological Chemistry|August 12, 2004
Insulin-like growth factor-1 regulates endogenous RUNX2 activity in endothelial cells through a phosphatidylinositol 3-kinase/ERK-dependent and Akt-independent signaling pathwayMeng Qiao, Paul Shapiro, Rakesh Kumar, et al.
Current Opinion in Pharmacology|May 4, 2020
Kinase inhibitors in the treatment of obstructive pulmonary diseasesAmy E Defnet, Jeffery D Hasday, Paul Shapiro
Anti-Cancer Drugs|October 24, 2002
Inhibition of aldose reductase enhances HeLa cell sensitivity to chemotherapeutic drugs and involves activation of extracellular signal-regulated kinasesEun Kyoung Lee, William T Regenold, Paul Shapiro
Journal of Cell Communication and Signaling|December 24, 2008
Using Caenorhabditis elegans as a model organism for evaluating extracellular signal-regulated kinase docking domain inhibitorsFengming Chen, Alexander D Mackerell, Yuan Luo, et al.
Journal of Hand Surgery Global Online|March 28, 2023
Suture Fixation of Subacute Pediatric Seymour FracturesEthan Graham Englert, Trevor Tooley, Kevin Weisz, et al.
Cellular Signalling|June 1, 2005
Inhibition of mixed-lineage kinase (MLK) activity during G2-phase disrupts microtubule formation and mitotic progression in HeLa cellsHyukjin Cha, Surabhi Dangi, Carolyn E Machamer, et al.
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Animals : an Open Access Journal From MDPI|May 16, 2017
A Decade of Progress toward Ending the Intensive Confinement of Farm Animals in the United StatesSara Shields, Paul Shapiro, Andrew Rowan
The Journal of Biological Chemistry|January 18, 2005
Protein phosphatase 2A activity associated with Golgi membranes during the G2/M phase may regulate phosphorylation of ERK2Chad N Hancock, Surabhi Dangi, Paul Shapiro
Advances in Pharmacology (San Diego, Calif.)|July 31, 2023
Progress in the development of kinase inhibitors for treating asthma and COPDNathaniel McClean, Jeffery D Hasday, Paul Shapiro
The Journal of Biological Chemistry|November 25, 2010
Quantitative analysis of ERK2 interactions with substrate proteins: roles for kinase docking domains and activity in determining binding affinityKimberly A Burkhard, Fengming Chen, Paul Shapiro
The Journal of Biological Chemistry|August 12, 2004
Insulin-like growth factor-1 regulates endogenous RUNX2 activity in endothelial cells through a phosphatidylinositol 3-kinase/ERK-dependent and Akt-independent signaling pathwayMeng Qiao, Paul Shapiro, Rakesh Kumar, et al.
Current Opinion in Pharmacology|May 4, 2020
Kinase inhibitors in the treatment of obstructive pulmonary diseasesAmy E Defnet, Jeffery D Hasday, Paul Shapiro
Anti-Cancer Drugs|October 24, 2002
Inhibition of aldose reductase enhances HeLa cell sensitivity to chemotherapeutic drugs and involves activation of extracellular signal-regulated kinasesEun Kyoung Lee, William T Regenold, Paul Shapiro
Journal of Cell Communication and Signaling|December 24, 2008
Using Caenorhabditis elegans as a model organism for evaluating extracellular signal-regulated kinase docking domain inhibitorsFengming Chen, Alexander D Mackerell, Yuan Luo, et al.
Journal of Hand Surgery Global Online|March 28, 2023
Suture Fixation of Subacute Pediatric Seymour FracturesEthan Graham Englert, Trevor Tooley, Kevin Weisz, et al.
Cellular Signalling|June 1, 2005
Inhibition of mixed-lineage kinase (MLK) activity during G2-phase disrupts microtubule formation and mitotic progression in HeLa cellsHyukjin Cha, Surabhi Dangi, Carolyn E Machamer, et al.
Pageof 8